What Researchers Did
Researchers documented the case of a 75-year-old man with a nonhealing nasal wound following squamous cell carcinoma resection and radiation, treated with hyperbaric oxygen therapy and dehydrated human amnion/chorion membrane (dHACM) grafting.
What They Found
After initial hyperbaric oxygen therapy, a dHACM graft was applied, leading to a 45% decrease in defect size after four applications. This combined approach ultimately resulted in complete reepithelialization and resolution of the patient's symptoms.
What This Means for Canadian Patients
For Canadian patients facing persistent nonhealing wounds after cancer treatment, this case suggests a potential alternative when standard care or surgery is not feasible or successful. It highlights the possibility of using advanced wound care products like dHACM in conjunction with hyperbaric oxygen therapy.
Canadian Relevance
This study does not have a direct Canadian connection as it was not conducted in Canada or by Canadian researchers.
Study Limitations
As a single case study, the findings cannot be generalized to a broader patient population.